 | • レポートコード：MRC23Q36263 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の末梢動脈血管形成術市場について調査・分析し、世界の末梢動脈血管形成術市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（バルーン血管形成術、ステント留置術）、用途別セグメント分析（下肢、腎動脈、頸動脈）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Medtronic, Inc.、BD、Boston Scientific Corporation、Abbott Laboratories、Cordis、Acotec、Biotronik、Terumo Corporation、Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd.、Cook Medical、Lepu Medical、Zylox-Tonbridge Medical Technology Co., Ltd.、LeoMed、LifeTech Scientific Corporationなどが含まれています。 世界の末梢動脈血管形成術市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、末梢動脈血管形成術市場規模を推定する際に考慮しました。本レポートは、末梢動脈血管形成術の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、末梢動脈血管形成術に関するビジネス上の意思決定に役立てることを目的としています。 ・末梢動脈血管形成術市場の概要 - 末梢動脈血管形成術のタイプ別セグメント - 世界の末梢動脈血管形成術市場規模：タイプ別分析（バルーン血管形成術、ステント留置術） - 末梢動脈血管形成術の用途別セグメント - 世界の末梢動脈血管形成術市場規模：用途別分析（下肢、腎動脈、頸動脈） - 世界の末梢動脈血管形成術市場規模予測（2018年-2029年） ・末梢動脈血管形成術市場の成長トレンド - 末梢動脈血管形成術の地域別市場規模（2018年-2029年） - 末梢動脈血管形成術市場ダイナミクス - 末梢動脈血管形成術の業界動向 - 末梢動脈血管形成術市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：バルーン血管形成術、ステント留置術 - 世界の末梢動脈血管形成術のタイプ別市場規模（2018年-2023年） - 世界の末梢動脈血管形成術のタイプ別市場規模（2024年-2029年） ・用途別セグメント：下肢、腎動脈、頸動脈 - 世界の末梢動脈血管形成術の用途別市場規模（2018年-2023年） - 世界の末梢動脈血管形成術の用途別市場規模（2024年-2029年） ・末梢動脈血管形成術の地域別市場規模 - 北米の末梢動脈血管形成術市場規模（2018年-2029年） - アメリカの末梢動脈血管形成術市場規模（2018年-2029年） - ヨーロッパの末梢動脈血管形成術市場規模（2018年-2029年） - アジア太平洋の末梢動脈血管形成術市場規模（2018年-2029年） - 中国の末梢動脈血管形成術市場規模（2018年-2029年） - 日本の末梢動脈血管形成術市場規模（2018年-2029年） - 韓国の末梢動脈血管形成術市場規模（2018年-2029年） - インドの末梢動脈血管形成術市場規模（2018年-2029年） - オーストラリアの末梢動脈血管形成術市場規模（2018年-2029年） - 中南米の末梢動脈血管形成術市場規模（2018年-2029年） - 中東・アフリカの末梢動脈血管形成術市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Medtronic, Inc.、BD、Boston Scientific Corporation、Abbott Laboratories、Cordis、Acotec、Biotronik、Terumo Corporation、Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd.、Cook Medical、Lepu Medical、Zylox-Tonbridge Medical Technology Co., Ltd.、LeoMed、LifeTech Scientific Corporation ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Peripheral Artery Angioplasty market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Peripheral Artery Angioplasty is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Peripheral Artery Angioplasty is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Peripheral Artery Angioplasty in Lower Limbs is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Peripheral Artery Angioplasty include Medtronic, Inc., BD, Boston Scientific Corporation, Abbott Laboratories, Cordis, Acotec, Biotronik, Terumo Corporation and Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peripheral Artery Angioplasty, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Artery Angioplasty.
The Peripheral Artery Angioplasty market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Peripheral Artery Angioplasty market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Artery Angioplasty companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Medtronic, Inc.
BD
Boston Scientific Corporation
Abbott Laboratories
Cordis
Acotec
Biotronik
Terumo Corporation
Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd.
Cook Medical
Lepu Medical
Zylox-Tonbridge Medical Technology Co., Ltd.
LeoMed
LifeTech Scientific Corporation
Segment by Type
Balloon Angioplasty
Stent Implantation
Segment by Application
Lower Limbs
Renal Artery
Carotid Artery
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peripheral Artery Angioplasty companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Artery Angioplasty Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Balloon Angioplasty
1.2.3 Stent Implantation
1.3 Market by Application
1.3.1 Global Peripheral Artery Angioplasty Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Lower Limbs
1.3.3 Renal Artery
1.3.4 Carotid Artery
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Artery Angioplasty Market Perspective (2018-2029)
2.2 Peripheral Artery Angioplasty Growth Trends by Region
2.2.1 Global Peripheral Artery Angioplasty Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Peripheral Artery Angioplasty Historic Market Size by Region (2018-2023)
2.2.3 Peripheral Artery Angioplasty Forecasted Market Size by Region (2024-2029)
2.3 Peripheral Artery Angioplasty Market Dynamics
2.3.1 Peripheral Artery Angioplasty Industry Trends
2.3.2 Peripheral Artery Angioplasty Market Drivers
2.3.3 Peripheral Artery Angioplasty Market Challenges
2.3.4 Peripheral Artery Angioplasty Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Artery Angioplasty Players by Revenue
3.1.1 Global Top Peripheral Artery Angioplasty Players by Revenue (2018-2023)
3.1.2 Global Peripheral Artery Angioplasty Revenue Market Share by Players (2018-2023)
3.2 Global Peripheral Artery Angioplasty Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peripheral Artery Angioplasty Revenue
3.4 Global Peripheral Artery Angioplasty Market Concentration Ratio
3.4.1 Global Peripheral Artery Angioplasty Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Artery Angioplasty Revenue in 2022
3.5 Peripheral Artery Angioplasty Key Players Head office and Area Served
3.6 Key Players Peripheral Artery Angioplasty Product Solution and Service
3.7 Date of Enter into Peripheral Artery Angioplasty Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Artery Angioplasty Breakdown Data by Type
4.1 Global Peripheral Artery Angioplasty Historic Market Size by Type (2018-2023)
4.2 Global Peripheral Artery Angioplasty Forecasted Market Size by Type (2024-2029)
5 Peripheral Artery Angioplasty Breakdown Data by Application
5.1 Global Peripheral Artery Angioplasty Historic Market Size by Application (2018-2023)
5.2 Global Peripheral Artery Angioplasty Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Peripheral Artery Angioplasty Market Size (2018-2029)
6.2 North America Peripheral Artery Angioplasty Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Peripheral Artery Angioplasty Market Size by Country (2018-2023)
6.4 North America Peripheral Artery Angioplasty Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peripheral Artery Angioplasty Market Size (2018-2029)
7.2 Europe Peripheral Artery Angioplasty Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Peripheral Artery Angioplasty Market Size by Country (2018-2023)
7.4 Europe Peripheral Artery Angioplasty Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Artery Angioplasty Market Size (2018-2029)
8.2 Asia-Pacific Peripheral Artery Angioplasty Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Peripheral Artery Angioplasty Market Size by Region (2018-2023)
8.4 Asia-Pacific Peripheral Artery Angioplasty Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peripheral Artery Angioplasty Market Size (2018-2029)
9.2 Latin America Peripheral Artery Angioplasty Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Peripheral Artery Angioplasty Market Size by Country (2018-2023)
9.4 Latin America Peripheral Artery Angioplasty Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Artery Angioplasty Market Size (2018-2029)
10.2 Middle East & Africa Peripheral Artery Angioplasty Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Peripheral Artery Angioplasty Market Size by Country (2018-2023)
10.4 Middle East & Africa Peripheral Artery Angioplasty Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic, Inc.
11.1.1 Medtronic, Inc. Company Detail
11.1.2 Medtronic, Inc. Business Overview
11.1.3 Medtronic, Inc. Peripheral Artery Angioplasty Introduction
11.1.4 Medtronic, Inc. Revenue in Peripheral Artery Angioplasty Business (2018-2023)
11.1.5 Medtronic, Inc. Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD Peripheral Artery Angioplasty Introduction
11.2.4 BD Revenue in Peripheral Artery Angioplasty Business (2018-2023)
11.2.5 BD Recent Development
11.3 Boston Scientific Corporation
11.3.1 Boston Scientific Corporation Company Detail
11.3.2 Boston Scientific Corporation Business Overview
11.3.3 Boston Scientific Corporation Peripheral Artery Angioplasty Introduction
11.3.4 Boston Scientific Corporation Revenue in Peripheral Artery Angioplasty Business (2018-2023)
11.3.5 Boston Scientific Corporation Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Peripheral Artery Angioplasty Introduction
11.4.4 Abbott Laboratories Revenue in Peripheral Artery Angioplasty Business (2018-2023)
11.4.5 Abbott Laboratories Recent Development
11.5 Cordis
11.5.1 Cordis Company Detail
11.5.2 Cordis Business Overview
11.5.3 Cordis Peripheral Artery Angioplasty Introduction
11.5.4 Cordis Revenue in Peripheral Artery Angioplasty Business (2018-2023)
11.5.5 Cordis Recent Development
11.6 Acotec
11.6.1 Acotec Company Detail
11.6.2 Acotec Business Overview
11.6.3 Acotec Peripheral Artery Angioplasty Introduction
11.6.4 Acotec Revenue in Peripheral Artery Angioplasty Business (2018-2023)
11.6.5 Acotec Recent Development
11.7 Biotronik
11.7.1 Biotronik Company Detail
11.7.2 Biotronik Business Overview
11.7.3 Biotronik Peripheral Artery Angioplasty Introduction
11.7.4 Biotronik Revenue in Peripheral Artery Angioplasty Business (2018-2023)
11.7.5 Biotronik Recent Development
11.8 Terumo Corporation
11.8.1 Terumo Corporation Company Detail
11.8.2 Terumo Corporation Business Overview
11.8.3 Terumo Corporation Peripheral Artery Angioplasty Introduction
11.8.4 Terumo Corporation Revenue in Peripheral Artery Angioplasty Business (2018-2023)
11.8.5 Terumo Corporation Recent Development
11.9 Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd.
11.9.1 Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd. Company Detail
11.9.2 Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd. Business Overview
11.9.3 Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd. Peripheral Artery Angioplasty Introduction
11.9.4 Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd. Revenue in Peripheral Artery Angioplasty Business (2018-2023)
11.9.5 Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd. Recent Development
11.10 Cook Medical
11.10.1 Cook Medical Company Detail
11.10.2 Cook Medical Business Overview
11.10.3 Cook Medical Peripheral Artery Angioplasty Introduction
11.10.4 Cook Medical Revenue in Peripheral Artery Angioplasty Business (2018-2023)
11.10.5 Cook Medical Recent Development
11.11 Lepu Medical
11.11.1 Lepu Medical Company Detail
11.11.2 Lepu Medical Business Overview
11.11.3 Lepu Medical Peripheral Artery Angioplasty Introduction
11.11.4 Lepu Medical Revenue in Peripheral Artery Angioplasty Business (2018-2023)
11.11.5 Lepu Medical Recent Development
11.12 Zylox-Tonbridge Medical Technology Co., Ltd.
11.12.1 Zylox-Tonbridge Medical Technology Co., Ltd. Company Detail
11.12.2 Zylox-Tonbridge Medical Technology Co., Ltd. Business Overview
11.12.3 Zylox-Tonbridge Medical Technology Co., Ltd. Peripheral Artery Angioplasty Introduction
11.12.4 Zylox-Tonbridge Medical Technology Co., Ltd. Revenue in Peripheral Artery Angioplasty Business (2018-2023)
11.12.5 Zylox-Tonbridge Medical Technology Co., Ltd. Recent Development
11.13 LeoMed
11.13.1 LeoMed Company Detail
11.13.2 LeoMed Business Overview
11.13.3 LeoMed Peripheral Artery Angioplasty Introduction
11.13.4 LeoMed Revenue in Peripheral Artery Angioplasty Business (2018-2023)
11.13.5 LeoMed Recent Development
11.14 LifeTech Scientific Corporation
11.14.1 LifeTech Scientific Corporation Company Detail
11.14.2 LifeTech Scientific Corporation Business Overview
11.14.3 LifeTech Scientific Corporation Peripheral Artery Angioplasty Introduction
11.14.4 LifeTech Scientific Corporation Revenue in Peripheral Artery Angioplasty Business (2018-2023)
11.14.5 LifeTech Scientific Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details